The brochure's purpose supports investigators in assessing risk-benefit for which aspect?

• A. The regulatory approval timeline
• B. The fundraising plan
• C. The appropriateness of the proposed trial
• D. The marketing strategy

Answer: (C)

The main idea is that the Investigator’s Brochure is used to weigh whether the expected benefits of the investigational product justify the risks in the context of the proposed study. It brings together safety data, pharmacology, and prior clinical findings to inform decisions about the study design, including who to include, what dose to use, how closely to monitor participants, and which endpoints to pursue. This helps determine if the trial is scientifically and ethically appropriate. It isn’t focused on regulatory approval timelines, fundraising plans, or marketing strategy, which lie outside the investigator’s risk-benefit assessment of the trial itself. So the brochure supports judging the appropriateness of the proposed trial.